Birmingham

ECMC Birmingham

Birmingham ECMC aims to improve the feasibility and quality of research in the areas of immunotherapy and gene therapy, translational genetics and biomarkers. This is being conducted in many different types of cancer. The Centre has established bio-repositories, developed antibody-based assays and conducted various immunotherapy/gene therapy trials.

Research Areas

Focus

Immunotherapy, Gene therapy, Biomarkers

Disease Area

Basic research, bladder, cervical, colon, rectal, Hodgkins lymphoma, Kaposi's sarcoma, Leukaemia, liver, lung, melanoma, myeloma, nasal, prostate

 

Goals

Goals

For further information on the goals and objectives of Birmingham ECMC go to:

More about Goals

 

Skills

Skills

Birmingham ECMC principal investigators and staff have a range of skills and expertise.

More about Skills

 

Facilities

Facilities

Birmingham ECMC has access to a range of research facilities that are utilised in studies. 

More about Facilities

 

Achievements

Achievements

To learn more about the scientific and operational achievements of Birmingham ECMC go to:

Achievements

 

Centre Lead

Professor Dion Morton
The University of Birmingham
College of Medical and Dental Sciences
School of Cancer Sciences
Academic Department of Surgery
4th Floor, Queen Elizabeth Hospital
Edgbaston
Birmingham
B15 2TH
Tel: +44 (0) 121 627 2276
Fax: +44 (0) 121 472 1230

 

Centre Administration and Contact

Dr. Johanna Dean
Administration Manager, School of Cancer Sciences
Tel: +44 (0) 121 414 7945

Jayne Doran
Tel: +44 (0) 121 414 6788

You can also find out about trials recruiting in Birmingham on the CancerHelp UK clinical trials database.